Rare diseases
Investigational molecules
Locations
245 1st Street, 02142-1200, United States
Avalyn Pharma Inc. focuses on inhaled and nebulized therapies for idiopathic pulmonary fibrosis and broader interstitial lung diseases, with attention to progressive forms of fibrosing lung disease.
The sponsor’s clinical work centers on lung scarring disorders where preserving respiratory function is a major therapeutic goal.
Avalyn Pharma Inc. runs clinical trials in conditions such as Idiopathic pulmonary fibrosis, Pulmonary fibrosis, Interstitial lung disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
Czechia
BelgiumCzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
